Skip to main content
. 2018 Apr 26;5:31. doi: 10.3389/fnut.2018.00031

Table 2.

Behaviors in Hojin formulations ((9), revised).

Pharmacological action Clinical effect
    Calcium channel inhibitor Anti-atherogenic effect
    Beta receptor agonist Improvement of urinary disturbance
    Protein kinase C inhibitor Improvement of coldness in legs
Anticoagulant and antithrombogenic activities Improvement of numbness in legs
Superoxide dismutase mimicking activity
Lipid metabolism regulation
Glycometabolism regulation
Diuretic activity
Improvement of kidney function